Lab-Grown Antivenom Shows Potential for Curing Black Mamba Snakebite
Antivenoms could one day be made in the lab instead of in animals. Researchers from…
Antivenoms could one day be made in the lab instead of in animals. Researchers from…
Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of…
Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer…
British researchers and a Danish biotech have joined forces to develop a polymer patch that…
Saniona, a biotech focused on ion channel research, plans to test its lead candidate in…
The capital of one of the happiest countries in the world, Copenhagen has become a…
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
Biosyntia has raised €4M in Series A financing from Sofinnova Partners to bring its microbe engineering…
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
Update (14/03/2018): Acesion Pharma has started a Phase I clinical trial at the Centre for…
Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody…
Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing…